Seegene succeeds in developing reagents using AI for the first time

Seegene succeeded in developing a molecular diagnosis reagent only in 4 days with its self-developed automated AI reagent development system.

Seegene(CEO Jong-Yoon Chun), a molecular diagnosis company, announced on the 3^rd the company succeeded in developing a meningoencephalitis reagent and a high multiplex real-time PCR reagent which diagnose sexually transmitted diseases using artificial in...